Trials / Sponsors / Chengdu Origen Biotechnology Co., Ltd.
Chengdu Origen Biotechnology Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gen Age-Related Macular Degeneration | Phase 1 | 2025-04-07 |
| Recruiting | Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (n Age-related Macular Degeneration | Phase 1 / Phase 2 | 2024-06-28 |
| Active Not Recruiting | Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneratio Age-Related Macular Degeneration | Phase 1 | 2023-10-16 |
| Recruiting | Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (n Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2023-02-06 |